SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
The Ethics of Intellectual Property Rights in an Era of Globalization
16 references·1 citing·31 second hop
The Ethics of Intellectual Property Rights in an Era of Globalization (2013)The Ethics of Intellectual Property Right…Anarchy, State, and Utopia (2018)Anarchy, State, and UtopiaThe Age of Discontinuity (2017)The Age of DiscontinuitySecond Treatise of Government and A Letter Concerning Toleration (2016)Second Treatise of Government…Estimating The Cost Of New Drug Development: Is It Really $802 Million? (2006)Estimating The Cost Of New Dr…The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries (2005)The WTO and India's Pharmaceu…Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases (2005)Strong Medicine: Creating Inc…Powerful medicines: the benefits, risks, and costs of prescription drugs (2005)Powerful medicines: the benef…The TRIPS Agreement: Drafting History and Analysis (2003)The TRIPS Agreement: Drafting…Information Feudalism: Who Owns the Knowledge Economy? (2003)Information Feudalism: Who Ow…TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha. (2002)TRIPS, pharmaceutical patents…Access to Essential Drugs in Poor Countries (1999)Access to Essential Drugs in …The Relationship Between Intellectual Property Rights and Foreign Direct Investment (1998)The Relationship Between Inte…GLOBAL PROPERTY RIGHTS IN INFORMATION: The story of TRIPS at the GATT (1995)GLOBAL PROPERTY RIGHTS IN INF…Justifying intellectual property (1989)Justifying intellectual prope…Anarchy, State, and Utopia (1975)Anarchy, State, and UtopiaThe Age of Discontinuity. Guidelines to Our Changing Society (1970)The Age of Discontinuity. Gui…Pharmaceutical patenting and the transformation of American medical ethics (2016)Pharmaceutical patenting and …Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery (1996)The price of innovation: new estimates of drug development costs (2003)American Society of Clinical Oncology Guidance Statement: The Cost of Cancer Care (2009)The cost of drug development: A systematic review (2011)The productivity crisis in pharmaceutical R&D (2011)A Dynamic Theory of Organizational Knowledge Creation (1994)The nonsense of 'knowledge management' (2002)Determinants of green competitive advantage: the roles of green knowledge sharing, green dynamic capabilities, and green service innovation (2016)Toward A Unified Conception Of Business Ethics: Integrative Social Contracts Theory (1994)Rethinking Multiculturalism: Cultural Diversity and Political Theory (2003)Conflict and Compromise: Drama in Marketplace Evolution (2008)The Socio-Economics of Geographical Indications (2004)Patent rights and innovative activity: evidence from national and firm-level data (2007)Driving a decade of change: HIV/AIDS, patents and access to medicines for all (2011)Pharmaceuticals and the Developing World (2002)Access to medicines from a health system perspective (2012)The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment (2013)Aliens and Citizens: The Case for Open Borders (1987)Equality of Opportunity (1998)Democratic Deficit: Critical Citizens Revisited (2011)The Global Diffusion of Regulatory Capitalism (2005)The Political Economy of the World Trading System (2009)Assetization (2020)The Socialist System (1992)Inclusion and Democracy (2002)The Measurement of Intellectual Property Rights Protection (2000)A Philosophy of Intellectual Property (2016)Digital commons (2020)On Global Order (2007)Managing Expert Knowledge: Organizational Challenges and Managerial Futures for the UK Medical Profession (2009)Self-Determination Theory in Human Resource Development: New Directions and Practical Considerations (2018)
this work references cited by second hop

References

  • 1975Anarchy, State, and Utopia7,692 cited
  • 2018Anarchy, State, and Utopia6,631 cited
  • 1970The Age of Discontinuity. Guidelines to Our Changing Society1,026 cited
  • 2017The Age of Discontinuity955 cited
  • 2006Estimating The Cost Of New Drug Development: Is It Really $802 Million?906 cited
  • 2003Information Feudalism: Who Owns the Knowledge Economy?826 cited
  • 2003The TRIPS Agreement: Drafting History and Analysis397 cited
  • 1999Access to Essential Drugs in Poor Countries396 cited
  • 1989Justifying intellectual property333 cited
  • 2016Second Treatise of Government and A Letter Concerning Toleration318 cited
  • 2005Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases237 cited
  • 1995GLOBAL PROPERTY RIGHTS IN INFORMATION: The story of TRIPS at the GATT202 cited
  • 2005Powerful medicines: the benefits, risks, and costs of prescription drugs191 cited
  • 2002TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.190 cited
  • 2005The WTO and India's Pharmaceuticals Industry: Patent Protection, TRIPS, and Developing Countries161 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1998
The Relationship Between Intellectual Property Rights and Foreign Direct Investment
153 cited

Cited by

  • 2016Pharmaceutical patenting and the transformation of American medical ethics27 cited